Most recent by Ravi Salgia, MD, PhD
VIDEO: ‘Revolutionary’ treatment findings in early-stage lung cancer presented at ASCO
Ravi Salgia, MD, PhD, spoke with Healio about a study assessing the safety and efficacy of three cycles of neoadjuvant sintilimab plus platinum-doublet chemotherapy compared with two cycles in patients with early-stage lung cancer.
VIDEO: Recognizing importance of CNS penetration in EGFR-mutated lung cancer
In this video, Ravi Salgia, MD, PhD, highlighted two studies that investigated treatment for EGFR-mutated non-small cell lung cancer presented at ASCO Annual Meeting.
VIDEO: ASCO highlights ‘important’ presentations on targeted, immunotherapy in lung cancer
In this video, Ravi Salgia, MD, PhD, discussed findings from two studies presented at ASCO Annual Meeting — one investigating immunotherapy and the other targeted therapy — for the treatment of lung cancer.
VIDEO: Ravi Salgia, MD, PhD, receives Excellence in Teaching award at ASCO
In this video, Ravi Salgia, MD, PhD, discussed the 2022 Excellence in Teaching Award he received at ASCO Annual Meeting.
VIDEO: Immunotherapy alone shows benefit in older patients with NSCLC
Ravi Salgia, MD, PhD, spoke with Healio about findings presented at ASCO Annual Meeting from a FDA pooled analysis of first-line treatment options for patients with PD-L1 advanced non-small cell lung cancer.